The adipogenic function and other biological effects of insulin

Pleiades Publishing Ltd - 2016
Yu. A. Pankov1
1Endocrinology Research Centre, Moscow, Russia

Tóm tắt

Studies on experimental animals with knockout of the insulin receptor gene (Insr) in the whole body or in certain tissues and/or related genes encoding proteins involved in realization of insulin signal transduction in target cells, have made an important contribution to the elucidation of insulin regulation of metabolism, particularly fat metabolism. Since the whole insulin secreted by β-cells, together with the products of gastrointestinal tract digestion of proteins, fats, and carbohydrates reaches in the liver, the latter is the first organ on which this hormone acts. The liver employs released amino acids for synthesis of proteins, including apo-proteins for various lipoproteins. Glucose is used for synthesis of glycogen, fatty acids, and triglycerides, which enter all the organs in very low density lipoproteins (VLDL). The LIRKO mice with knockout of the insr gene in the liver demonstrated inhibition of synthesis of macromolecular compounds from amino acids, glucose, and fatty acids. Low molecular weight substances demonstrated increased entry to circulation, and together with other disorders induced hyperglycemia. In LIRKO mice blood glucose levels and glucose tolerance demonstrated time-dependent normalization and at later stages the increase in glucose levels was replaced by hypoglycemia. These changes can be well explained if we take into consideration that one of the main functions of insulin consists in stimulation of energy accumulation by means of activation of triglyceride deposition in adipose tissue. FIRKO mice with selective knockout of adipose tissue Insr were characterized by decreased uptake of glucose in adipocytes, and its transformation into lipids. However, the level of body fat in animals remained normal, possibly due to preserved insulin receptor in the liver and insulin-induced activation of triglyceride production which maintained normal levels of body fat stores, the effective functioning of adipose tissue and secretion of leptin by adipocytes during inhibition of glucose transformation into triglyceride in adipose tissue. Knockout of the Insr gene in muscles blocked glucose uptake by myocytes, but it did not induce hyperglycemia, probably due to the increase in glucose uptake by other organs, which retained the insulin receptor, and induced some increase in fat resources in adipose tissue. Similar results were obtained in mice with knockout the glucose transporter 4 GLUT4 in muscle and/or adipose tissue. Insulin microinjections in the brain, in the cerebral ventricle 4 (CVI) and mediobasal hypothalamus (MBH) did not affect the insulin levels in the general circulation, but effectively activate lipogenesis and inhibited lipolysis in adipose tissue. They induced obesity, similar to conventional obesity when the insulin levels increased. These results may serve as an additional confirmation of the importance of the adipogenic insulin function in mechanisms of regulation of general metabolism.

Từ khóa


Tài liệu tham khảo

Bunting, F.G. and Best, C.H., J. Lab. Clin. Med., 1922, vol. 7, pp. 251–266.

Banting, F.G., Best, C.H., Collip, J.B., et al., Trans. Assoc. Am. Physicians, 1922, vol. 34, pp. 337–347.

Roth, J., Queresni, S., Whitford, I., Vranic, M., Kahn, C.R., Fantus, G., and Dirck, J.H., Diabetes Metab. Res. Rev., 2012, vol. 28, pp. 293–304.

Sanger, F. and Tuppy, H., Biochem. J., 1951, vol. 49, pp. 463–481.

Sanger, F. and Tuppy, H., Biochem. J., 1951, vol. 49, pp. 481–490.

Sanger, F. and Tompson, E.O.P., Biochem. J., 1953, vol. 53, pp. 353–366.

Sanger, F. and Tompson, E.O.P., Biochem. J., 1953, vol. 53, pp. 366–374.

Nandi, A., Kitamura, Y., Kahn, C.R., and Accili, D., Physiol. Rev., 2003, vol. 84, pp. 623–647. doi 10.1152/physrev.00032.2003

Widdowson, E.M., Nature, 1950, vol. 166, pp. 626–628.

Kahn, C.R., Experimental Diab. Res., 2003, vol. 4, pp. 169–182. doi 10.1080/15438600390261408

Accili, D., Diabetes, 2004, vol. 53, pp. 1633–1642.

Michaek, M.D., Kulkarni, R.N., Postic, C., Previs, S.F., Shulman, G.I., Magnussen, M.A., and Kahn, C.R., Molecular. Cell., 2000, vol. 6, pp. 87–97.

Okamoto, H., Obici, S., Accili, D., and Rosetti, L., J. Clin. Invest., 2005, vol. 115, pp. 1314–1322. doi 10.1172/JCI200523096

Brüning, J.C., Michael, M.D., Winnay, J.N., Hayashi, T., Hörsch, D., Accili, D., Goodyear, L.J., and Kahn, C.R., Molecular Cell., 1998, vol. 2, pp. 559–569. doi 10.1016/S1097-2765(00)80155-0

Blüher, M., Michael, M.D., Peroni, O.D., Ueli, K., Carter, N., Kahn, B.B., and Kahn, C.R., Cell, 2002, vol. 3, pp. 25–38. doi 10.1016/S1534-5807(02)00199-5

Kulkarni, R.N., Brüning, J.C., Winnay, J.N., Postic, C., Madnuson, M.A., and Kahn, C.R., Cell, 1999, vol. 96, pp. 329–339.

Okada, T., Liew, C.W., Hu, J., Hinault, C., Michael, M.D., Krützfedt, J., Yin, C., Holzenberger,M., Stoffel, M., and Kulkarni, R., Proc. Natl. Acad. Sci. USA, 2007, vol. 104, pp. 8977–8982.

Vicent, D., Ilany, J., Kondo, T., Naruse, K., Fisher, S.J., Kisanuki, Y.Y., Bursell, S., Yanagisawa, M., King, G.L., and Kahn, C.R., J. Clin. Invest., 2003, vol. 111, pp. 1373–1380. doi 10.1172/JCI1200315211

Rask-Madsen, C., Li, Q., Freund, B., Feather, D., Abramov, R., Wu, I.-H., Chen, K., YamamotoHiraoka, J., Goldenbogen, J., Sotiropoulos, K.B., Clermont, A., Geraldes, P., Dall’Osso, C., Wegers A., Huang, P.L., Rekhter, M., Scalla, R., Kahn, C.R., and King, G.L., Cell Metab., 2010, vol. 11, pp. 379–389. doi 10.1016/jcmet.2010.03.013

Rask-Madsen, C. and Kahn, C.R., Arterioscler. Thromd. Vasc. Biol., 2012, vol. 32, pp. 2052–2059. doi 10.1161/ATVBANA.111.241919

Abel, E.D., Peroni, O., Kim, J.K., Kim, Y.B., Boss, O., Hadro, E., Minnemann, T., Shulman, G.I., and Kahn, B.B., Nature, 2001, vol. 409, pp. 729–733.

Zisman, A., Peroni, O.D., Abel, E.D., Michael, M.D., Mauvais-Jarvis, F., Lowell, B.B., Wojtaszewski, J.F., Hirshman, M.F., Virkamaki, A., Goodyear, L.J., Kahn, C.R., Kahn, B.B., Nat. Med., 2000, vol. 6, pp. 924–928.

Konani, K., Peroni, O.D., Minokoshi, Y., Boss, O., and Khan, B.B., J. Clin. Invest., 2004, vol. 114, pp. 1666–1675. doi 10.1172/JCI12000421341

Randle, P.J., Diabetes Metab. Rev., 1998, vol. 14, pp. 263–283.

Roden, M., News Physiol. Sci., 2004, vol. 19, pp. 92–96. doi 10.1152/nips.01459.2003

Pankov, Yu.A., Mol. Biol. (Moscow), 2013, vol. 47, pp. 891–899.

Brüning, J.C., Gautam, D., Burks, D.J., Gillette, J., Schubert, M., Orban, P.C., Klein, R., Krone, W., Müller- Wieland, M., and Kahn, C.R., Science, 2000, vol. 289, pp. 2122–2125. doi 10.1126/science.289.5487.2122

Scherer, T., O’Hare, J., Diggs-Andrews, K., Schweiger, M., Cheng, B., Lindtner, C., Zielinski, E., Wempati, P., Su, K., Dighe, S., Milson, T., Puchowicz, M., Scheja, L., Zechner, R., Fisher, J., Previs, S., and Buettner, C., Cell Metab., 2011, vol. 13, pp. 183–194. doi 10.1016/jcmet.2011.01.008

TitovL, V.N., Vestnik Rus. Akad. Med. Nauk, 2005, no. 2, pp. 3–8.

Titov, V.N., Klin. Lab. Diagn., 2012, no. 5, pp. 3–12.

Thông tin
Thông tin xuất bản

Pleiades Publishing Ltd

Thông tin tác giả